PubRank

A Modesti

Author PubWeight™ 105.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J 1995 3.48
2 The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001 2.92
3 Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med 1998 2.08
4 Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J 1998 1.50
5 Establishment and characterization of a human neuroblastoma cell line. Int J Cancer 1989 1.43
6 Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res 1992 1.39
7 Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. Lab Invest 1999 1.37
8 Group B streptococci persist inside macrophages. Immunology 1998 1.36
9 Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J Natl Cancer Inst 1997 1.30
10 The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood 1999 1.25
11 Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J Immunol 1995 1.23
12 Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci U S A 1982 1.21
13 Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol 1992 1.15
14 Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int J Cancer 1993 1.15
15 IFN-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells. J Immunol 1994 1.14
16 HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia. Science 1987 1.10
17 Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res 1999 1.08
18 IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci 1995 1.08
19 Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J Exp Med 1996 1.08
20 Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. J Immunol 1987 1.07
21 Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ 1991 1.05
22 Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus. J Virol 2008 1.04
23 Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J Immunol 1990 1.02
24 A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth. Cancer Lett 2008 1.02
25 Type V collagen in human amnion is a 12 nm fibrillar component of the pericellular interstitium. Eur J Cell Biol 1984 1.01
26 A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. J Immunol 1999 1.01
27 Heterozygote detection in cystinosis, using leukocytes exposed to cystine dimethyl ester. N Engl J Med 1982 0.99
28 Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest 1996 0.99
29 Cytokines, tumour-cell death and immunogenicity: a question of choice. Immunol Today 1997 0.98
30 Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. Blood 1997 0.97
31 An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol 1994 0.95
32 5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J Immunol 1995 0.95
33 Looking for residues involved in the muscle acylphosphatase catalytic mechanism and structural stabilization: role of Asn41, Thr42, and Thr46. Biochemistry 1996 0.94
34 Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res 1993 0.91
35 Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma. Exp Cell Res 1996 0.90
36 Neutrophils in anti-cancer immunological strategies: old players in new games. J Hematother Stem Cell Res 2001 0.89
37 Arginine-23 is involved in the catalytic site of muscle acylphosphatase. Biochim Biophys Acta 1994 0.89
38 Different carbon sources affect lifespan and protein redox state during Saccharomyces cerevisiae chronological ageing. Cell Mol Life Sci 2009 0.88
39 Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. J Biol Regul Homeost Agents 2013 0.88
40 An ultrastructural study of recurrent disc herniation: a preliminary report. Spine (Phila Pa 1976) 1983 0.88
41 Heavy metal toxicity following apical and basolateral exposure in the human intestinal cell line Caco-2. Toxicol In Vitro 1996 0.85
42 Neuromodulatory loop mediated by nerve growth factor and interleukin 6 in thymic stromal cell cultures. Proc Natl Acad Sci U S A 1992 0.85
43 A new acylphosphatase isoenzyme from human erythrocytes: purification, characterization, and primary structure. Biochemistry 1986 0.84
44 Multiplex PCR analysis and genotype-phenotype correlations of frequent APC mutations. Hum Mutat 1995 0.84
45 [Bone marrow changes in HIV-positive patients (clinical, cytological, histological, and ultrastructural study of 57 cases)]. Pathologica 1997 0.84
46 HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt. Eur J Epidemiol 1999 0.84
47 Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. J Biol Regul Homeost Agents 2012 0.83
48 Rat Leydig cells bind platelet-derived growth factor through specific receptors and produce platelet-derived growth factor-like molecules. Endocrinology 1992 0.82
49 The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int J Immunopathol Pharmacol 2004 0.82
50 Expression and synthesis of fibronectin and laminin by an intestinal epithelial cell line. Tissue Cell 1988 0.81
51 Letterer-Siwe disease: immunohistochemical evidence for a proliferative disorder involving immature cells of Langerhans lineage. Virchows Arch A Pathol Anat Histopathol 1988 0.81
52 Vitamin D receptor in IMR-90 human fibroblasts and antiproliferative effect of 1,25-dihydroxyvitamin D3. Biochem Mol Biol Int 1997 0.81
53 Effect of chronic hyperoxia on young and old rat carotid body ultrastructure. Exp Gerontol 1998 0.81
54 Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines. Gene Ther 1997 0.81
55 Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action. Naunyn Schmiedebergs Arch Pharmacol 1993 0.81
56 Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells. J Virol 1991 0.81
57 Rat natural killer cells synthesize fibronectin. Possible involvement in the cytotoxic function. J Immunol 1989 0.80
58 Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice. J Interferon Cytokine Res 1999 0.80
59 Tumour inhibition by interleukin-2 at the tumour/host interface. Biochim Biophys Acta 1986 0.80
60 A novel mutation at the splice junction of exon 9 of the APC gene in familial adenomatous polyposis. Hum Mutat 1994 0.80
61 Modulation of fibronectin and thymic stromal cell-dependent thymocyte maturation by retinoic acid. J Immunol 1994 0.80
62 SV40 expression in human neoplastic and non-neoplastic tissues: perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma. Dev Biol Stand 1998 0.80
63 Overexpression of a synthetic phosphotyrosine protein phosphatase gene inhibits normal and transformed cell growth. Int J Cancer 1992 0.79
64 Cloning of murine low molecular weight phosphotyrosine protein phosphatase cDNA: identification of a new isoform. FEBS Lett 1998 0.79
65 Expression of acylphosphatase in Saccharomyces cerevisiae enhances ethanol fermentation rate. Biotechnol Appl Biochem 1996 0.79
66 Chemical synthesis and expression of a gene coding for bovine liver phosphotyrosine-protein phosphatase. Biochem Int 1991 0.79
67 Immunohistology of adenolymphoma (Warthin's tumour): evidence for a role of vascularization in the organization of the lympho-epithelial structure. Histopathology 1987 0.79
68 Cytokine-induced tumor immunogenicity: from exogenous cytokines to gene therapy. J Immunother Emphasis Tumor Immunol 1993 0.79
69 A new childhood T-cell lymphoma established in nude mice and in vitro. Cancer Res 1988 0.79
70 Platelet-derived growth factor effects on purified testicular peritubular myoid cells: binding, cytosolic Ca2+ increase, mitogenic activity, and extracellular matrix production enhancement. Endocrinology 1993 0.79
71 Xenotransplantation in immunosuppressed nude mice of human solid tumors and acute leukemias directly from patients or in vitro cell lines. Ric Clin Lab 1990 0.79
72 The complete amino acid sequence of the low molecular weight cytosolic acid phosphatase. J Biol Chem 1989 0.79
73 Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour. J Pathol 1998 0.79
74 Immunity to extracellular matrix antigens is associated with ultrastructural alterations of the stroma and stratified epithelium basement membrane in the skin of Hashimotos thyroiditis patients. Int J Immunopathol Pharmacol 2006 0.78
75 Migration of mesothelioma cells correlates with histotype-specific synthesis of extracellular matrix. Int J Mol Med 1999 0.78
76 Small cell lung cancer cell lines: pure and variant types can be distinguished by their extracellular matrix synthesis. Eur Respir J 1988 0.78
77 Retinoic acid negatively regulates beta 4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma cell line. Clin Exp Metastasis 1994 0.78
78 Laminin synthesis by NK cells and modulation of its expression by TPA (12-O-tetradecanoylphorbol-13-acetate). Exp Cell Res 1989 0.78
79 Immotile cilia syndrome: radial spokes deficiency in a patient with Kartagener's triad. Acta Paediatr Scand 1981 0.78
80 Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection. Eur Cytokine Netw 1998 0.78
81 Extracellular matrix synthesis by undifferentiated childhood tumor cell lines. Am J Pathol 1987 0.78
82 Human acylphosphatase cannot replace phosphoglycerate kinase in Saccharomyces cerevisiae. Antonie Van Leeuwenhoek 2001 0.78
83 Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genes. Nat Immun 1994 0.78
84 The 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesions. Exp Dermatol 1997 0.78
85 Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. J Pathol 1997 0.78
86 Ewing's sarcoma lines synthesize laminin and fibronectin. Virchows Arch A Pathol Anat Histopathol 1987 0.78
87 Heterogeneity of thymic stromal cells and thymocyte differentiation: a cell culture approach. J Cell Sci 1993 0.77
88 Interferon gamma modifies fibronectin and laminin synthesis in human neuroblastoma cell lines. Int J Oncol 1998 0.77
89 Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant. Gene Ther 1997 0.77
90 Expression of the Stp1 LMW-PTP and inhibition of protein CK2 display a cooperative effect on immunophilin Fpr3 tyrosine phosphorylation and Saccharomyces cerevisiae growth. Cell Mol Life Sci 2004 0.77
91 Ultrastructural and immunohistochemical characterization of the tunica albuginea in Peyronie's disease and veno-occlusive dysfunction. J Androl 1996 0.77
92 Role of extracellular matrix in regulation of staurosporine-induced apoptosis in breast cancer cells. Oncol Rep 2005 0.77
93 The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis. Am J Pathol 1998 0.77
94 Human malignant melanoma. Significance of chromosomal abnormalities. Cancer Genet Cytogenet 1990 0.77
95 Effect of acute increase of interstitial myocardial fluid on ventricular function in isolated working rat hearts. J Med 1998 0.77
96 Cure of mice with established metastatic friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir. Hum Gene Ther 1996 0.77
97 Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth. Hum Gene Ther 1995 0.77
98 Endomorphin-1 inhibits the activation and the development of a hyporesponsive-like phenotype in lipopolysaccharide- stimulated THP-1 monocytes. Int J Immunopathol Pharmacol 2009 0.77
99 Ligation of either CD2 or CD28 rescues CD4+ T cells from HIV-gp120-induced apoptosis. Eur J Immunol 1995 0.77
100 Epidermal growth factor promotes a neural phenotype in thymic epithelial cells and enhances neuropoietic cytokine expression. J Cell Biol 1995 0.77
101 Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta. Invasion Metastasis 1993 0.77
102 Modulation of laminin synthesis in human neuroblastoma cells during retinoic acid induced differentiation. Cancer Lett 1992 0.76
103 Lymphocyte proliferative response in brown bears: cytokine role and glucocorticoid effect. J Exp Zool 1998 0.76
104 Targeting cytokine/chemokine receptors: a challenge for molecular nuclear medicine. Eur J Nucl Med Mol Imaging 2002 0.76
105 Defective response to T cell mitogens in mice injected with human immunodeficiency virus type 1-infected U937 cells. J Gen Virol 1994 0.76
106 Insulin-sperm interaction: effects on plasma membrane and binding to acrosome. Arch Androl 1992 0.76
107 Tumor immunotherapy by local injection of interleukin 2 and non-reactive lymphocytes. Experimental and clinical results. Prog Exp Tumor Res 1988 0.76
108 Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta. Endocrinology 2000 0.76
109 Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression. Int J Cancer 2000 0.76
110 Preferential accumulation of muscle type acylphosphatase in the nucleus during differentiation. Biochem Mol Biol Int 1999 0.76
111 Human immunodeficiency virus type 1 tat protein modulates fibronectin expression in thymic epithelial cells and impairs in vitro thymocyte development. Cell Immunol 1996 0.75
112 [Role of interstitial myocardium in ischemia-reperfusion injury: experimental data and clinical implications]. Cardiologia 1994 0.75
113 The endolymphatic sac as the immunocompetent organ of the inner ear. Ann N Y Acad Sci 1997 0.75
114 Properties of N-terminus truncated and C-terminus mutated muscle acylphosphatases. FEBS Lett 1995 0.75
115 Ultrastructural nuclear changes in human lymphocytes following arabinosylcytosine treatment in vitro. Virchows Arch B Cell Pathol 1978 0.75
116 Prostaglandin-induced storage and secretion of esteroproteases in the mouse submaxillary gland. Cytobios 1986 0.75
117 [Therapeutic trends in gastric polyps]. Minerva Dietol Gastroenterol 1984 0.75
118 Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer. Biochem Pharmacol 1986 0.75
119 Differentiating and biochemical effects of a reduction of intracellular GTP levels induced by mycophenolic acid (MPA) in human neuroblastoma (NB) cell lines. Adv Exp Med Biol 1998 0.75
120 Lentigo maligna. Cytogenetic, ultrastructural, and phenotypic characterization of a primary cell culture. Cancer Genet Cytogenet 1992 0.75
121 Extracellular matrix remodelling in a murine mammary adenocarcinoma transfected with the interferon-alpha 1 gene. J Pathol 1997 0.75
122 Guinea pig acylphosphatase: the amino acid sequence. J Protein Chem 1988 0.75
123 Transforming growth-factor-alpha modulates replication and differentiation markers on a human neuroblastoma cell-line. Int J Oncol 1994 0.75
124 Modulation of integrin expression on mesotheliomas: the role of different histotypes in invasiveness. Int J Oncol 1999 0.75
125 Supernumerary microtubules in the cilia of two siblings causing "immotile cilia syndrome". Eur J Respir Dis 1983 0.75
126 [Gastroduodenal adenomatous lesions in familial diffuse polyposis]. Minerva Dietol Gastroenterol 1984 0.75
127 [Ultrastructural and immunoelectron microscopic study of the desmoplastic stroma in carcinoma of the breast]. G Chir 1989 0.75
128 Human malignant mesothelioma of the pleura: new perspectives for diagnosis and therapy. Monaldi Arch Chest Dis 1998 0.75
129 [The absence of the internal arms of dynein as a cause of the immotile cilia syndrome]. Pediatr Med Chir 1985 0.75
130 Placenta growth factor is a survival factor for human malignant mesothelioma cells. Int J Immunopathol Pharmacol 2009 0.75
131 Changes in fibronectin production in rat liver during cirrhotic evolution due to treatment with CCl4 and steroid hormones: correlation with plasmatic fibronectin. Pathologica 1993 0.75
132 Expression of human acylphosphatase in Escherichia coli affects intracellular calcium levels. Biochem Mol Biol Int 1994 0.75
133 Preparation of pure fractions of human sperm membranes. Arch Androl 1980 0.75
134 [Diagnostic use of the cell culture technique in a case of postoperative saccate lymphorrhea]. G Chir 1989 0.75
135 [Postischemic changes in the permeability of coronary microcirculation and ventricular remodeling]. Cardiologia 1995 0.75
136 Basal lamina reduplication in malignant epithelioid pleural mesothelioma. Ultrastruct Pathol 1999 0.75
137 Perilymphatic injections of cytokines: a new tool in active cancer immunotherapy. Experimental rationale and clinical findings. Ann Ist Super Sanita 1990 0.75
138 Human skeletal muscle acylphosphatase: the primary structure. Mol Biol Med 1984 0.75
139 Lymphokine-activated tumor inhibition: combinatory activity of a synthetic nonapeptide from interleukin-1, interleukin-2, interleukin-4, and interferon-gamma injected around tumor-draining lymph nodes. Int J Cancer Suppl 1989 0.75
140 [Ultrastructural endometrial changes in IUD users]. Patol Clin Ostet Ginecol 1990 0.75
141 [Use of argon laser in experimental liver surgery]. Minerva Chir 1987 0.75
142 Harmless technique for removal of the cell coat from human spermatozoa. Experientia 1982 0.75
143 Nuclear changes in Friend erythroleukemia cells treated with arabinosylcytosine in vitro. Int J Tissue React 1984 0.75
144 [The use of imidazole-2-hydroxybenzoate in sport trauma. Multidisciplinary study in professional athletes]. Boll Chim Farm 1986 0.75
145 Effects of prazosin on the cAMP system in the spontaneously hypertensive rat (SHR) aorta. Eur J Pharmacol 1980 0.75
146 [Ultrastructural aspects of the submandibular gland]. Minerva Stomatol 1989 0.75
147 Immunohistochemical characterization of a B-cell signet ring cell lymphoma. Report of a case. Pathol Res Pract 1988 0.75
148 The complete amino acid sequence of bovine skeletal muscle acylphosphatase. Ital J Biochem 1986 0.75
149 Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages. J Immunol 1993 0.75
150 Variation of the symmetrical/asymmetrical ratio in chromatid interchanges during the various phases of the cell cycle of human lymphocytes "in vitro". Mutat Res 1979 0.75
151 [Gastric polyps. Pathologic study and histogenetic classification]. Minerva Dietol Gastroenterol 1984 0.75
152 [Extracellular matrix in gingival fibroblasts]. Dent Cadmos 1991 0.75
153 Nerve fibres of the endolymphatic sac: electronmicroscopic findings in the Mongolian gerbil. Hear Res 1995 0.75
154 Thymectomy and multiple sclerosis: ultrastructural study of an experimental model. G Chir 1999 0.75
155 Phenotypic and morphological characterization of neuroblastoma cells constitutively expressing B-myb. J Neurooncol 1997 0.75
156 Small early gastric cancer with special reference to macrophage infiltration. Mod Pathol 1999 0.75
157 Zinc uptake in human seminal spermatozoa: characterization and effects on cell membranes. Arch Androl 1989 0.75
158 Effect of intraoperative manipulation and preservation on fascia temporalis used in tympanoplasty. Acta Otorhinolaryngol Belg 1993 0.75